In order to ensure high product differentiation, the leading players in the global mice model market are focusing on extensive research and development. Transparency Market Research (TMR) observes that the rising trend of outsourcing mice models to pharmaceutical companies and contract research organizations (CRO) in emerging markets has increased competition as well as market growth. The leading players in the global market are Charles River, The Jackson Laboratory, Harlan Laboratories, and Taconic Biosciences Inc.
The global mice model market was valued at US$1.06 bn in 2015 and is expected to reach US$1.74 bn by 2023, rising at a CAGR of 6.4% between 2015 and 2023. By specialty, the metabolism and regulation segment dominated the market in terms of revenue in 2015. However, oncology will surpass this segment by 2016. The increasing incidence of cancer and the high overall cost of cancer are constantly pushing companies to develop more efficient therapeutics. This, in turn, has increased the demand for mice models in the field of oncology. The diabetes segment is expected to exhibit a noteworthy CAGR of 10.4% during the forecast period owing to the rising prevalence of diabetes.
Presence of Large Number of Research Institutions to Put North America at Forefront
North America will continue to remain the leading geographical segment until 2023, reaching a valuation of US$785.4 mn that year. The presence of a large number of biopharmaceutical companies and research institutions has been instrumental in driving the growth of the region. Asia Pacific is likely to expand at a CAGR of 11.1% during the same period. Factors such as rising healthcare expenditure, improving research infrastructure, and conducive regulatory environment are contributing to the growth of the Asia Pacific mice model market.
Launch of Advanced Mice Models to Stimulate Market Growth
In the past few years, the market has experienced an influx of several mice models. “The development of advanced mice models is not only boosting the application, but also the applicability of these models for complex diseases,” says TMR’s lead analyst. For instance, in 2015, the ALS Association-funded project created a mouse model of the disease using the mutant C9orf72 gene. The model is expected to be highly valuable in studying the disease process and testing therapies against this form of the disease. The development of such models is augmenting market as well as attracting funds for biomedical research. Moreover, the introduction of personalized in vivo analysis mice models, fueled by the need for fast and accurate treatment, is bolstering the growth of the global market.
Rising Concerns Regarding Animal Use to Take its Toll on Mice Model Market
Globally, the increasing concerns regarding the usage of animals for research and teaching purposes are restraining the growth of the mice model market. Several international social organizations such as PETA believe that the use of animals is morally unacceptable and it should be banned. TMR predicts that the agitation against animal use would grow further in the future, which might slow down the growth of the animal research industry.
With so many sophisticated non-animal product tests now available, companies are looking for alternative tools that are faster and more cost-effective than animal tests. Although these technologies are still in development phases, these would hamper the growth of the animal research industry.
The information presented in this review is based on a Transparency Market Research report, titled,Mice Model Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015–2023.”
The key segments of the global mice model market are:-
Global Mice Models Market, by Type
Global Mice Models Market, by Specialty
Global Mice Models Market, by Services
Global Mice Models Market, by Geography
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453